1101P - Oral mucosa dose parameters predicting grade ≥3 acute toxicity in locally advanced nasopharyngeal carcinoma patients treated with concurrent intens...

Date 10 September 2017
Event ESMO 2017 Congress
Session Poster display session
Topics Cancer in Adolescents
Complications of Treatment
Head and Neck Cancers
Palliative and Supportive Care
Surgery and/or Radiotherapy of Cancer
Presenter Kaixin Li
Citation Annals of Oncology (2017) 28 (suppl_5): v372-v394. 10.1093/annonc/mdx374
Authors K. Li1, L. Yang2, Y. Chen3, M. Chen3
  • 1Department Of Radiation Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, 362000 - Quanzhou/CN
  • 2Department Of Oncology, Xinyu Peole’s Hospital, 336500 - Xinyu/CN
  • 3Radiotherapy, Zhejiang Cancer Hospital, 310022 - Hangzhou/CN



To determine whether volumes based on the contours of the mucosal surface can be used instead of the contours of the oral cavity to predict for grade ≥3 acute oral mucosa toxicity in patients with locally advanced nasopharyngeal carcinoma (LANPC) treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.


A standardized method for the oral cavity (oral cavity contours, OCC) and a novel method for the mucosal surface (mucosal surface contours, MSC) were developed for the oral mucosa and prospectively applied to the radiation treatment plans of 92 patients treated with concurrent IMRT and chemotherapy for LANPC. Dose–volume histogram (DVH) data were extracted and analyzed against patient toxicity. Receiver operating characteristic analysis and logistic regression were carried out for both contouring methods.


Grade ≥3 oral mucosa toxicity occurred in 20.7% (19/92) of patients in the study. A highly significant dose–volume relationship between oral mucosa irradiation and acute oral mucosa toxicity was supported by using both oral cavity and mucosal surface contouring techniques. In logistic regression, body weight loss was an independent factor related to grade ≥3 toxicity for OCC and MSC (p=0.017 and 0.005, respectively), and the independent factor of dosimetric parameters for OCC and MSC were V30Gy (p=0.003) and V50Gy (p=0.003), respectively. In the receiver operating characteristics curve, the areas under V30Gy of the OCC curves was 0.753 (p=0.001), and the areas under V50Gy of MSC curves was 0.714 (p=0.004); the cut-off value was 73.155% (sensitivity, 0.842; specificity, 0.671) and 14.32% (sensitivity, 0.842; specificity, 0.575), respectively.


DVH analysis of mucosal surface volumes accurately predicts grade ≥3 oral mucosa toxicity in patients with LANPC receiving concurrent IMRT and chemotherapy, but the MSC method is still no better than the OCC method in clinical application.

Clinical trial identification


Legal entity responsible for the study

Yuanyuan Chen




All authors have declared no conflicts of interest.